EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Factors associated with women’s choice for mode of cervical sampling in future cervical cancer screening

Natalija Berza iD, Jana Zodzika, Anda Kivite-Urtane, Alise Curkste, Ilva Pole, Mari Nygard, Kersti Parna, Anneli Uuskula

PLOS One · 09.07.2026 · 21 (7) · e0353180

DOI: 10.1371/journal.pone.0353180 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, online erschienen am 09.07.2026. Verfasst von Natalija Berza und 7 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Public Health, Riga Stradins University, Riga, Latvia. Hauptthemen laut MEDLINE: Uterine Cervical Neoplasms, Early Detection of Cancer, Vaginal Smears, Papillomavirus Infections. Die Arbeit nennt 60 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: EEA Grants, Estonian Research Competency Council.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Cervical cancer (CC), primarily caused by persistent high-risk human papillomavirus (HR-HPV) infection, remains a major public health challenge, with Latvia experiencing substantially higher incidence and mortality rates than the European average. HR-HPV self-sampling is an effective and acceptable screening method, yet some women continue to prefer clinician-collected sampling. Evidence on factors associated with reluctance to adopt self-sampling in the Baltic region is limited. This study examined demographic, socioeconomic, behavioral, and health-related characteristics linked to women’s preferences for future cervical cancer screening modalities. Materials and methods This cross-sectional study was conducted in Latvia between February 2021 and April 2022. Women attending general practitioners or the Colposcopy Unit of Riga East University Hospital were invited to perform unsupervised HR-HPV self-sampling using written and visual instructions, followed by a structured questionnaire. Collected data included demographic and socioeconomic characteristics, health status, health behaviours, emotional responses to self-sampling, and preferred sampling modality for the next screening round. Descriptive statistics and Chi-square tests were used to assess differences in emotional responses and preferences. Factors associated with preferred sampling modality were identified through univariate and multivariate multinomial logistic regression. Statistical significance was set at p < 0.05.

Results

A total of 1,217 women were included. Overall, 45.9% preferred clinician-collected cervical sampling, 42.6% preferred self-sampling, and 11.5% expressed no clear preference. Women who preferred self-sampling reported significantly lower embarrassment and discomfort during the procedure (p < 0.001). Most participants expressed positive emotional responses. The main reason for preferring clinician-collected sampling (81.0%) was a lack of confidence in performing self-sampling correctly. Multivariate analysis showed a higher preference for clinician-collection among women recruited from colposcopy settings and those with more recent gynecological visits, whereas former or occasional smokers were less likely to prefer clinician collection. Higher BMI (≥25) and non-Latvian nationality were associated with indecision regarding future sampling preference.

Conclusion

HR-HPV self-sampling was generally well accepted and may help engage women less likely to attend traditional screening. Preference for clinician-collection was shaped mainly by medical history and nationality. Emotional factors may also influence screening choices and should be considered in future implementation strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Uterine Cervical NeoplasmsEarly Detection of CancerVaginal SmearsPapillomavirus InfectionsHumansFemaleCross-Sectional StudiesAdultMiddle AgedLatviaSpecimen HandlingChoice BehaviorHuman Papillomavirus VirusesSurveys and Questionnaires

Autor:innen und Institutionen

  • Institute of Public Health, Riga Stradins University, Riga, Latvia.
  • Riga East University Hospital, Riga, Latvia.
  • Cancer Registry of Norway, Oslo, Norway.
  • Institute of Family Medicine and Public Health, University of Tartu, Tartu, Estonia.

ORCID-Profile: Natalija Berza

Förderung

  • EEA Grants
  • Estonian Research Competency Council

Zitieren

APA

Berza, N., Zodzika, J., Kivite-Urtane, A., Curkste, A., Pole, I., Nygard, M., Parna, K., & Uuskula, A. (2026). Factors associated with women’s choice for mode of cervical sampling in future cervical cancer screening. PLOS One, 21(7), e0353180. https://doi.org/10.1371/journal.pone.0353180

Vancouver

Berza N, Zodzika J, Kivite-Urtane A, Curkste A, Pole I, Nygard M, et al. Factors associated with women’s choice for mode of cervical sampling in future cervical cancer screening. PLOS One. 2026;21(7):e0353180. doi:10.1371/journal.pone.0353180

BibTeX
@article{Berza2026,
  author = {Berza, Natalija and Zodzika, Jana and Kivite-Urtane, Anda and Curkste, Alise and Pole, Ilva and Nygard, Mari and Parna, Kersti and Uuskula, Anneli},
  title = {Factors associated with women’s choice for mode of cervical sampling in future cervical cancer screening},
  journal = {PLOS One},
  year = {2026},
  volume = {21},
  number = {7},
  pages = {e0353180},
  doi = {10.1371/journal.pone.0353180}
}
Kostenlos starten →